A Study to Compare the Efficacy of Triamcinolone 0.1% Cream Occluded With Hydrogel Patch to Triamcinolone 0.1% Cream Without Occlusion in the Treatment of Eczema
| Status: | Archived |
|---|---|
| Conditions: | Skin and Soft Tissue Infections, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | July 2008 |
| End Date: | September 2010 |
The primary objective of this clinical study is to determine whether occlusion of
triamcinolone 0.1% cream (TAC) used to treat eczema with hydrogel patch improves its
efficacy. A secondary objective is to determine whether eczema improves under occlusion
with hydrogel patch alone.
This will be a 6-week, open label, bilaterally-controlled single center study involving 30
subjects age 13 and older with eczema. The primary objective of this clinical study is to
determine whether occlusion of triamcinolone 0.1% cream (TAC) used to treat eczema with
hydrogel patch improves its efficacy. A secondary objective is to determine whether eczema
improves under occlusion with hydrogel patch alone. All subjects will have 3 target lesions
of similar severity followed throughout the study. Patients will apply hydrogel patch alone
to the first lesion, TAC 0.1% cream to the second lesion, and TAC 0.1% cream occluded by
hydrogel patch to the third lesion. All treatments are twice a day for a maximum of 4 weeks
or until lesions are cleared. The modified Eczema Area and Severity Index (EASI) score will
be used to evaluate each lesion.
We found this trial at
1
site
Click here to add this to my saved trials
